Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

Valent P, Akin C, Hartmann K, et al.

Cancer Res · 2017

Grade Bnarrative review

Key Findings

  • Classification refinements from consensus group, WHO, and ECNM
  • New treatment options including allogeneic HSCT and KIT D816V inhibitors

Referenced in (1 disease)

ID: pmid-28254862DOI: 10.1158/0008-5472.CAN-16-2234PMID: 28254862